Format

Send to

Choose Destination
Thorax. 2014 May;69(5):491-4. doi: 10.1136/thoraxjnl-2013-203897. Epub 2013 Sep 12.

Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS).

Author information

1
Department of Biostatistics, University of North Carolina at Chapel Hill, , Chapel Hill, North Carolina, USA.

Abstract

Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) is a multicentre observational study of chronic obstructive pulmonary disease (COPD) designed to guide future development of therapies for COPD by providing robust criteria for subclassifying COPD participants into groups most likely to benefit from a given therapy during a clinical trial, and identifying biomarkers/phenotypes that can be used as intermediate outcomes to reliably predict clinical benefit during therapeutic trials. The goal is to enrol 3200 participants in four strata. Participants undergo a baseline visit and three annual follow-up examinations, with quarterly telephone calls. Adjudication of exacerbations and mortality will be undertaken.

KEYWORDS:

COPD Exacerbations; COPD epidemiology; Emphysema; Imaging/CT MRI etc

PMID:
24029743
PMCID:
PMC3954445
DOI:
10.1136/thoraxjnl-2013-203897
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center